Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Ovidrel and Pregnyl pharmacology in healthy men
ACTRN12609000462280Phase 4Completed
- Sponsor
- Concord Repatriation General Hospital
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human chorionic gonadotrophin and human chorionic gonadotropin in male infertility (4 arms), sponsored by Concord Repatriation General Hospital. Primary endpoint: Single-dose comparison of serum hCG and serum testosterone effects. Started Sep 2009; status: completed.
02
Drugs
recombinant human chorionic gonadotrophinhuman chorionic gonadotropin
03
Conditions
male infertility
Beyond the preview
Go deeper on ACTRN12609000462280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000462280.